Abstract
Background
It is widely accepted that congenital choledochal cyst is associated with pancreaticobiliary maljunction (PBM). But, PBM is an independent disease entity from choledochal cyst. PBM is synonymous with “abnormal junction of the pancreaticobiliary ductal system”, “anomalous arrangement of pancreaticobiliary ducts”, “anomalous union of bilio-pancreatic ducts”, etc. Cases with PBM not associated with biliary duct dilatation are often found, and these cases are frequently complicated gallbladder cancer. The Japanese Study Group of Pancreaticobiliary Maljunction was started in 1983, and defined diagnostic criteria and nationwide registration system of PBM cases was started. PBM is defined as a union of the pancreatic and biliary ducts which is located outside the duodenal wall. Bile and pancreatic juice reflux and regurgitate mutually.
Biliary carcinogenesis
The most bothersome problem is biliary carcinogenesis. Gallbladder cancers arise in 14.8% and bile duct cancers arise in 4.9%. The incidence of the gallbladder carcinoma of PBM without bile duct dilatation is 36.1%. Many investigators have tried to clarify the carcinogenic process, from various aspects. The biliary epithelia are injured by harmful substances, and in the course of repair, multiple alterations of oncogenes and tumor suppressor genes are followed, and they lead to carcinoma through multistage interaction. In the biliary epithelia of PBM, incidence and degree of hyperplasia are characteristic. K-ras gene mutations are observed in the cancerous as well as noncancerous lesions of biliary tract of PBM patients. Mutations of p53 gene and overexpression of p53 protein are also found in the cancerous and noncancerous lesions. These changes are called “hyperplasia–carcinoma sequence”.
Treatment
Total excision of the extrahepatic bile duct with gallbladder followed by hepaticojejunostomy, Roux-en-Y, or end-to-side hepaticoduodenostomy are treatment of choice, even for cases with not dilated bile duct, because the incidence of cancer in the nondilated bile duct is not negligible, and genetic changes are seen in a nondilated bile duct.
Similar content being viewed by others
References
Kelly TR, Schlueter TM (1964) Choledochal cyst with coexistent carcinoma of the pancreas. Am Surg 30:209–212
Komi N, Kunitomo K, Tamura T, Udaka H, Miyoshi Y, Takehara H (1984) Nationwide survey of cases of choledochal cyst: analysis of coexistent anomalies, complications and surgical treatment in 645 cases. Surg Gastroenterol 3:69–73
Kozumi K, Kodama T (1916) A case of cystic dilatation of the common bile duct and etiology of the disease (in Japanese). Tokyo Med J 30:1413–1423
Babbitt DP (1969) Congenital choledochal cysts: new etiological concept based on anomalous relationships of the common bile duct and pancreatic bulb. Ann Surg (Paris) 12:231–240
Hasumi A, Matsui H, Sugioka A, Uyama I, Komori Y, Fujita J, Aoki H (2000) Precancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction: reappraisal of nationwide survey in Japan. J Hepatobiliary Pancreat Surg 7:551–555
Yamao K, Mizutani S, Nakazawa S, Inui K, Kanemaki N, Miyoshi H, Segawa K, Zenda H, Kato T (1996) Prospective study of the detection of anomalous connection of pancreatobiliary ducts during routine medical examinations. Hepatogastroenterology 43:1238–1245
Mori K, Akimoto R, Kanno M, Kamata T, Hirono Y, Matsumura A (1999) Anomalous union of the pancreaticobiliary ductal system without dilatation of the common bile duct or tumor: cases report and literature review. Hepatogastroenterology 46:142–148
Yamauchi S, Koga A, Matsumoto S, Tanaka M, Nakayama F (1987) Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol 82:20–24
Chang LY, Wang HP, Wu MS, Hang HT, Wang HH, Lin CC, Lin JT (1998) Anomalous pancreaticobiliary ductal union—an etiologic association of gallbladder cancer and adenomyomatosis. Hepatogastroenterology 45:2016–2019
Tuech JJ, Pessaux P, Aube C, Regent N, Cervi C, Bergamaschi R, Aunaud JP (2000) Cancer of the gallbladder associated with pancreaticobiliary maljunction without bile duct dilatation in a European patient. J Hepatobiliary Pancreat Surg 7:336–338
Todani T, Arima E, Eto T, Funabiki T, Kakita A, Kimura K, Ohi R, Oi I, Matsumoto Y, Miyano T, Suda K, Takahara H, (JSPBM Committee for diagnostic criteria) (1994) Diagnostic criteria of pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 1:219–221
Adham M, Valette PJ, Partensky C (2005) Pancreaticobiliary maljunction without choledochal dilatation associated with gallbladder cancer: report of 2 European cases. Surgery 138:961
Dowdy GS, Waldron GW, Brown WD (1962) Surgical anatomy of the pancreaticobiliary ductal system. Arch Surg 84:229–246
Matsumoto Y, Fujii H Itakura J, Matsuda M, Yang Y Nobukawa B, Suda K (2003) Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis. Langenbeck’s Arch Surg 388:122–131
Kamisawa T, Funata N, Hayashi Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A, Yamaguchi T (2004) Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel. Gastrointest Endosc 60:56–60
Irwin ST, Morison JE (1944) Congenital cyst of the common bile duct containing stones and undergoing cancerous change. Br J Surg 33:261–270
Todani T, Watanabe Y, Toki A, Urushihara N (1987) Carcinoma related to choledochal cysts with internal drainage operations. Surg Gynecol Obstet 164:61–64
Rossi RL, Silverman ML, Braasch JW, Munson JL, Remine SG (1987) Carcinomas arising in cystic conditions of the bile ducts: a clinical and pathologic study. Ann Surg 205:377–384
Todani T, Watanabe Y, Fujii H, Toki, Uemura S, Koike Y, Inoue T (1985) Carcinoma arising from the bile duct in choledochal cyst and anomalous arrangement of the pancreaticobiliary ductal union. Tan to Sui (Biliary Tract Pancreas, in Japanese) 6:525–535
Okamoto A, Tsuruta K, Matsumoto G, Takahashi T, Kamisawa T, Egawa N, Funata N (2003) Papillary carcinoma of the extrahepatic bile duct: characteristic features and implications in surgical treatment. J Am Coll Surg 196:394–401
Tashiro S, Imaizumi T, Ohkawa H, Okada A, Katoh T, Kawaharada Y, Shimada H, Takamatsu H, Miyake H, Todani T (2003) Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg 10:345–351
Tanaka S, Kubota M, Yagi M, Okuyama N, Ohtani M, Yamazaki S, Hirayama Y, Kurosaki I, Hatakeyama K (2006) An 11-year-old male patient demonstrating cholangiocarcinoma associated with congenital biliary dilatation. J Pediatr Surg 41:E15–E19
Iwai N, Deguchi E, Yanagihara J, Iwai M, Matsuo H, Todo S, Imashuku S (1990) Cancer arising in a choledochal cyst in a 12-year-old girl. J Pediatr Surg 25:1261–1263
Ohuchida J, Chijiiwa K, Hiyoshi M, Kobayashi K, Konomi H, Tanaka M (2006) Long-term results of treatment of pancreaticobiliary maljunction without bile duct dilatation. Arch Surg 141:1066–1070
Ichikawa Y, Kamiyama M, Sekido H, Ishikawa T, Miura Y, Kamiya N, Morita T, Shimada H (2004) Telomerase activity and Bcl-2 expression in gallbladders of pancreaticobiliary maljunction patients: a preliminary study. J Hepatobiliary Pancreat Surg 11:34–39
Seki M, Yanagisawa A, Ninomiya E, Ninomiya Y, Ohta H, Saiura A, Yamamoto J, Yamaguchi T, Agura A, Yamada K, Takano K, Fujita R, Ikeda M, Sasaki K, Kato Y (2005) Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development. J Hepatobiliary Pancreat Surg 12:254–262
Fieber SS, Nance FC (1997) Choledochal cyst and neoplasm: a comprehensive review of 106 cases and presentation of two original cases. Am Surg 63:982–987
Funabiki T (2000) Pancreaticobiliary Maljunction—focused on biliary carcinogenesis (in Japanese). Jpn J Gastroenterol Surg 33:261–270
Okamura K, Hayakawa H, Kuze M, Takahashi H, Kosaka A, Mizumoto R, Katsuta K (2000) Triple carcinomas of the biliary tract associated with congenital choledochal dilatation and pancreaticobiliary maljunction. J Gastroenterol 35:465–471
Takayashiki T, Miyazaki M, Kato A, Ito H, Nakagawa K, Ambiru S, Shimizu H, Furuya S, Nakajima N (2002) Double cancer of gallbladder and bile duct associated with anomalous junction of the pancreaticobiliary ductal system. Hepatogastroenterology 49:109–112
Marugame T, Matsuda T, Kamo K, Katanoda K, Ajiki W, Sobue T, Japanese cancer surveillance research group (2007) Cancer incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. Jpn J Clin Oncol 37:884–891
Binks JB, Pauline GJ (1970) Choledochal cyst and carcinoma of the pancreas in a boy of fifteen years. Aust NZ J Surg 40:42–44
Tsuchida A, Kasuya K, Endo M, Saito H, Inoue K, Nagae I, Aoki T, Koyanagi Y (2003) High risk of bile duct carcinogenesis after primary resection of a congenital biliary dilatation. Oncol Rep 10:1183–1187
Yamashiro Y, Miyano T, Suruga K, Shimomura H, Suda K, Matsumoto M, Nittono H (1984) Experimental study of the pathogenesis of choledochal cyst and pancreatitis, with special reference to the role of bile acids and pancreatic enzymes in the anomalous choledocho-pancreatico ductal junction. J Pediatr Gastroenterol Nutr 3:721–727
Kato T, Matsuda K, Kayaba H, Enomoto S, Hebiguchi T, Koyama K, Hachiya N, Takizawa Y (1989) Pathology of anomalous junction of the pancreaticobiliary ductal system: mutagenicity of the contents of the biliary tract and nuclear atypia of the biliary epithelium. Keio J Med 38:167–176
Shimada K, Yanagisawa J, Nakayama F (1991) Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal system. Hepatology 13:438–444
Mizuno M, Kato T, Koyama K (1996) An analysis of mutagens in the contents of the biliary tract in pancreaticobiliary maljunction. Surg Today 26:597–602 (1996)
Takabayashi A, Soloway RD (1981) The role of bile acids in the pathogenesis of carcinoma of the gallbladder. Kitano Hospital J Med 26:153–160
Reveille RM, VanStiegmann G, Everson GT (1990) Increased secondary bile acids in a choledochal cyst. Gastroenterology 99:525–527
Funabiki T, Sugiue K, Matsubara T, Amano H, Ochiai M (1991) Bile acids and biliary carcinoma in pancreaticobiliary maljunction. Keio J Med. 40:118–122
Qian D, Kinouchi T, Kunitomo K, Kataoka K, Matin MA, Akimoto S, Komi N, Ohnishi Y (1993) Mutagenicity of the bile of dogs with an experimental model of an anomalous arrangement of the pancreaticobiliary duct. Carcinogenesis 14:743–747
Fortner JG (1957) An appraisal of the pathogenesis of primary carcinoma of the extrahepatic biliary tract. Surgery 43:563–571
Shimada K, Chijiiwa K, Yanagisawa J, Nakayama F (1993) Biliary bile acids in the gallbladder and the common bile duct of patients with anomalous pancreaticobiliary ductal system. J Gastroenterol Hepatol 8:138–141
Matsubara T, Tsuji A, Miyama H, Yamaguchi H, Funabiki T (1995) Mutagenicity of bile and pancreatic juice from patients with pancreatico-biliary maljunction. Hepatogastroenterol 42:113–116
Hanada K, Itoh M, Fujii K, Tsuchida A, Hirata M, Ishimaru S, Iwao T, Eguchi N, Kajiyama G (1996) Pathology and cellular kinetics of gallbladder with an anomalous junction of pancreaticobiliary duct. Am J Gastroenterol 91:1007–1011
Tanno S, Obara T, Fujii T, Mizukami Y, Shudo R, Nishino N, Ura H, Klein-Szanto AJ, Kohgo Y (1998) Proliferative potential and k-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer 83:267–275
Tsuchida A, Itoi T, Aoki T, Koyanagi Y (2003) Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review). Oncol Rep 10:1693–1699
Tokiwa K, Iwai N, Nakamura K, Okuzumi J, Yamane T, Takahashi T (1991) Gallbladder mucosa ornithine decarboxylase activity is increased in patients with anomalous arrangement of the pancreaticobiliary duct. Cancer 69:2440–2443
Hara H, Morita S, Ishibashi T, Sako S, Dohi T, Otani M, Iwamoto M, Inoue H, Tanigawa N (2002) Studies on biliary tract carcinoma in the case with pancreaticobiliary maljunction. Hepatogastroenterol 49:104–108
Isozaki H, Okajima K, Hara H, Sako S, Mabuchi H (1997) Proliferating cell nuclear antigen expression in the gallbladder with pancreaticobiliary maljunction. J Surg Oncol 65:46–49
Yamato T, Kurumaya H, Ohma K, Yamamichi N, Watanabe Y, Harada K, Sasaki M, Nakamura Y (1999) Frequent expression of mucin core protein MUC1 in non-neoplastic gallbladder mucosa from patients with pancreaticobiliary maljunction. Liver 19:281–287
Tsuchida A, Nagakawa Y, Kasuya K, Itoi T, Endo M, Ozawa T, Aoki T, Koyanagi Y (2003) Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction. Oncol Rep 10:339–343
Otani K, Shimizu S, Chijiiwa K, Yamaguchi K, Noshiro H, Tanaka M (2001) Immunohistochemical detection of 8-hydroxy-2′-deoxyguanosine in gallbladder epithelium of patients with pancreaticobiliary maljunction. Eur J Gastroenterol Hepatol 13:1363–1369
Nagai M, Watanabe M, Iwase T, Yamao K, Isaji S (2002) Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg 26:91–98
Miura Y, Ichikawa Y, Ishikawa T, Sekido H, Nakano A, Mitsuhashi M, Shimada H (1998) The elevated mRNA content as a potential indicator of precancerous states of the gallbladder mucosa in patients with pancreaticobiliary maljunction. Oncol Rep 5:845–851
Itoi T, Watanabe H, Yoshikawa T, Ajioka Y, Nishikura K, Saito T (1996) K-ras mutations in gallbladder carcinomas in patients with anomalous arrangement of the pancreaticobiliary duct. Acta Med Biol 44:71–77
Chao TC, Wang CS, Jan YY, Chen HM, Chen MF (1999) Carcinogenesis in the biliary system associated with APDJ. J Hepatobiliary Pancreat Surg 6:218–222
Matsubara T, Sakurai Y, Sasayama Y, Hori H, Ochiai M, Funabiki T (1996) K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer 77:1752–1757
Funabiki T, Matsubara T, Ochiai M, Marugami Y, Sakurai Y, Hasegawa S, Imazu H (1997) Biliary carcinogenesis in pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg 4:405–411
Matsubara T, Sakurai Y, Zhi L-Z, Miura H, Ochiai M, Funabiki T (2002) K-ras and p-53 gene mutations in noncancerous biliary lesions of patients with pancreatico biliary maljunction. J Hepatobiliary Pancreat Surg 9:312–321
Hanada K, Itoi M, Fujii K, Tsuchida A, Ooishi H, Kajiyama G (1996) K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 77:452–458
Wistuba II, Gazdar AF, Rosa I, Albores-Saavedra J (1996) p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 27:360–365
Zhi LZ, Matsubara T, Miura H, Nakamura Y, Hasegawa S, Imazu H, Sakurai Y, Ochiai M, Funabiki T (2001) p53 protein and p53 gene mutations in intrahepatic cholangiocarcinomas and extrahepatic bile duct carcinomas. Tandou (JJ Bil Assoc, in Japanese)
Ohashi Y, Watanabe H, Ajioka Y, Hatakeyama K (1995) p53 Immunostaining distinguishes malignant from benign lesions of the gallbladder. Pathol Int 45:58–65
Matsubara T, Funabiki T, Jinno O, Ochiai M, Sakurai Y, Hasegawa S, Imazu H (1999) Analysis of p53 loss of heterozygosity in patients with pancreaticobiliary maljunction by double target fluorescence in situ hybridation. Gekachiryou (in Japanese) 80:617–618
Matsubara T, Ishihara S, Miyakawa S, Ochiai M, Funabiki T (2003) Carcinogenic mechanism in pancreaticobiliary maljunction. Naika (in Japanese) 92:1171–1174
Yoshida S, Todoroki T, Ichikawa Y, Hanai S, Suzuki H, Fukao K, Miwa M, Uchida K (1995) Mutations of p16INK4/CDKN2 and p15INK4B/MTS2 genes in biliary tract cancers. Cancer Res 55:2756–2760
Todani T, Watanabe Y, Toki A (2003) Classification of congenital biliary cystic disease: special reference to type Ic and IVA cysts with primary ductal stricture. J Hepatobiliary Pancreat Surg 10:340–344
Stain SC, Guthrie CR, Yellin AE, Donovan AJ (1995) Choledochal cyst in the adult. Ann Surg 222:128–123
Todani T, Watanabe Y, Naruse M, Tabuchi K, Okajima K (1977) Congenital bile duct cysts: Classification, operative procedures, and review of thirty-seven cases including cancer arising from choledochal cyst. Am J Surg 134:263–269
Watanabe Y (2004) Development of bile duct cancer after surgery for pancreaticobiliary maljunction. Shounigeka (in Japanese) 36:495–500
Funabiki T, Matsubara T, Ochiai M, Marugami Y, Sakurai Y, Hasegawa S, Imazu H (1997) Surgical strategy for patients with pancreaticobiliary maljunction without choledochal dilatation. Keio J Med 46:169–172
Funabiki T, Ochiai M, Amano H, Sugiue K, Fujita S, Fukui H, Matsubara T, Kamei K, Yamaguchi H, Futawatari H, Hasegawa S, Arai K (1987) A new technique of total excision as to the affected bile duct on the congenital choledochal dilatation. Tandou (JJ Bil Assoc, in Japanese) 1:436–442
Funabiki T, Sakurai Y, Ochiai M, Marugami Y, Matsubara T, Hasegawa S (1997) End-to-side choledochoduodenostomy: a widely applicable procedure for biliary reconstruction. J Hepatobiliary Pancreat Surg 4:71–77
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funabiki, T., Matsubara, T., Miyakawa, S. et al. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch Surg 394, 159–169 (2009). https://doi.org/10.1007/s00423-008-0336-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-008-0336-0